The trials found that people using semaglutide lost more body weight than those taking a placebo
As such, targeting GLP-1R has become a prominent method for increasing insulin secretion in the treatment of T2DM, and it has been recently approved in adults as a therapy for obesity due to its ability to slow gastric emptying
Is tirzepatide hard on the liver
specializing in weight management, GLP-1 medication nutrition therapy, bariatric surgery, digestive health, and sustainable behavior change Leah Jones, MD Board-certified in Internal Medicine and Obesity Medicine Katherine Austin, MD, MPH, FAAP, FRCP(C) Board-certified in Pediatrics and Adolescent Medicine Heather Cecchini, MSN, APRN, ANP-C Board-certified Adult-Primary Care Nurse Practitioner Clete Barrick, MD Board-certified in Internal Medicine and Obesity Medicine Caitlin Camill, RDN, CDCES Certified Diabetes Care and Education Specialist
Alcohol combined with these factors and GLP-1 therapy requires careful medical evaluation
10.1038/s41598-017-15809-4 13